Sherry Black joined the RTI Drug Metabolism and Pharmokinetics (DMPK) group in 1989. She specializes in absorption, distribution, metabolism, and excretion (ADME) and pharmacokinetic studies in several in vivo test systems for commercial and government clients.
Ms. Black has directed regulated studies, and is experienced with all aspects of ADME studies using oral, dermal, and intravenous exposure routes. She has worked extensively to develop high performance liquid chromatography (HPLC) systems for analyzing xenobiotics and their metabolites in biological media.
Since 1997, Ms. Black has authored many publications about drug-drug interactions and pharmacokinetics. She has conducted numerous in vitro studies of drug metabolism using liver slices and microsomal preparations from humans and other species for cross-species comparisons. As study director, Ms. Black completed work on aromatase and estrogen receptor binding assay validation for the U.S. Environmental Protection Agency (EPA).